Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market

Eli Lilly has struck a deal to buy AtaiBeckley for $2.8 billion upfront, continuing its takeover spree to move into a psychedelic mental health sector targeted by companies including Johnson &…